Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Prostatic Neoplasms 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Leukemia 1Congenital Abnormalities 1Blast Crisis 1

Interventions

fludarabine phosphate 31Peripheral Blood Stem Cell Transplantation 26Cyclophosphamide 25Mycophenolic Acid 24Whole-Body Irradiation 23Busulfan 21Tacrolimus 19Cyclosporine 19Antilymphocyte Serum 14Methotrexate 13Imatinib Mesylate 12Cord Blood Stem Cell Transplantation 11Melphalan 10Dasatinib 10Cyclosporins 8nilotinib 7Methylprednisolone 7Etoposide 7Radiotherapy 6Filgrastim 6Alemtuzumab 6Sirolimus 5thymoglobulin 4sargramostim 4bosutinib 4Granulocyte Colony-Stimulating Factor 4Cytarabine 4fludarabine 3Thiotepa 3Rituximab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myeloid, Chronic-Phase × treosulfan × Clear all
NCT00796068 2023-02-17

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

Fred Hutchinson Cancer Center

Phase 2 Completed
130 enrolled 21 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡